26 October 2018 - Health and Human Services Secretary Alex Azar said Friday he would push ahead with drug pricing reforms despite pushback from the pharmaceutical industry.

“Finally seeing this system reformed, in fact, is one of the pharmaceutical industry’s ultimate nightmares," said Azar, a former Eli Lily executive, at a Brookings Institution event in Washington. "I can tell you that because it used to be my job to have pharmaceutical nightmares.”

“But now we have a president who is definitely not afraid of upsetting drug companies and isn’t afraid of taking on ostensibly invincible special interests,” he added.

Read The Hill article